Cargando…

Impact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC Study

OBJECTIVE: The aim of this study was to investigate the impact of adverse events (AEs) on health utility and health-related quality of life (HRQOL) in patients with metastatic breast cancer undergoing first-line chemotherapy. METHODS: We analyzed the data from the SELECT BC study, a multicenter, ope...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hagiwara, Yasuhiro, Shiroiwa, Takeru, Shimozuma, Kojiro, Kawahara, Takuya, Uemura, Yukari, Watanabe, Takanori, Taira, Naruto, Fukuda, Takashi, Ohashi, Yasuo, Mukai, Hirofumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805818/ https://www.ncbi.nlm.nih.gov/pubmed/29043567 http://dx.doi.org/10.1007/s40273-017-0580-7

Ejemplares similares

Minimal important differences of EORTC QLQ-C30 for metastatic breast cancer patients: Results from a randomized clinical trial
por: Kawahara, Takuya, et al.
Publicado: (2022)

Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial
por: Shiroiwa, Takeru, et al.
Publicado: (2017)

Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer
por: Hagiwara, Yasuhiro, et al.
Publicado: (2020)

Cost-Effectiveness of Trastuzumab With or Without Chemotherapy as Adjuvant Therapy in HER2-Positive Elderly Breast Cancer Patients: A Randomized, Open-Label Clinical Trial, the RESPECT Trial
por: Takumoto, Yuki, et al.
Publicado: (2022)

Impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent EQ-5D-5L
por: Izumi, Shoki, et al.
Publicado: (2023)

Long-term health status as measured by EQ-5D among patients with metastatic breast cancer: comparison of first-line oral S-1 and taxane therapies in the randomized phase III SELECT BC trial
por: Shiroiwa, T., et al.
Publicado: (2016)

Prospective Cohort Study of Palbociclib Treatment in Postmenopausal Patients With Unresectable and Metastatic Hormone Receptor-Positive Breast Cancer: Study Protocol for a CSPOR-BC Palbociclib Cohort Trial
por: Narui, Kazutaka, et al.
Publicado: (2022)

Association of change in health-related quality of life and treatment discontinuation in metastatic breast cancer: a post hoc, exploratory analysis of two randomized clinical trials
por: Kawahara, Takuya, et al.
Publicado: (2022)

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D
por: Shiroiwa, Takeru, et al.
Publicado: (2015)

Cost-effectiveness analysis of trastuzumab to treat HER2-positive advanced gastric cancer based on the randomised ToGA trial
por: Shiroiwa, T, et al.
Publicado: (2011)

Psychometric properties of the Japanese version of the EQ-5D-Y by self-report and proxy-report: reliability and construct validity
por: Shiroiwa, T., et al.
Publicado: (2019)

WTP for a QALY and health states: More money for severer health states?
por: Shiroiwa, Takeru, et al.
Publicado: (2013)

Rainbow of KIBOU (ROK) study: a Breast Cancer Survivor Cohort in Japan
por: Mizota, Yuri, et al.
Publicado: (2017)

EQ-5D-Y Population Norms for Japanese Children and Adolescents
por: Shiroiwa, Takeru, et al.
Publicado: (2021)

Prospective Cohort Study of Combination Therapy With Abemaciclib and Hormonal Therapy for Chemotherapy-Treated Patients With Hormone Receptor-Positive Metastatic Breast Cancer
por: Miyahara, Kana, et al.
Publicado: (2022)

Health-related quality of life and estimation of the minimally important difference in the Functional Assessment of Cancer Therapy-Endocrine Symptom score in postmenopausal ER+/HER2- metastatic breast cancer with low sensitivity to endocrine therapy
por: Kikawa, Yuichiro, et al.
Publicado: (2022)

Prospective cohort study of febrile neutropenia in breast cancer patients administered with neoadjuvant and adjuvant chemotherapies: CSPOR-BC FN study
por: Ishikawa, Takashi, et al.
Publicado: (2021)

Development of a multiplicative, multi-attribute utility function and eight single-attribute utility functions for the Health Utilities Index Mark 3 in Japan
por: Noto, Shinichi, et al.
Publicado: (2020)

Comparison of an AC‐taxane versus AC‐free regimen and paclitaxel versus docetaxel in patients with lymph node‐positive breast cancer: Final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial, a randomized comparative phase 3 study
por: Watanabe, Toru, et al.
Publicado: (2017)

Estimation of Lifetime QALYs Based on Lifestyle Behaviors
por: Noto, Shinichi, et al.
Publicado: (2021)

Adjuvant trastuzumab without chemotherapy for treating early HER2-positive breast cancer in older patients: A propensity score-adjusted analysis of a prospective cohort study
por: Sawaki, Masataka, et al.
Publicado: (2022)

Effect of achieved hemoglobin level on renal outcome in non-dialysis chronic kidney disease (CKD) patients receiving epoetin beta pegol: MIRcerA CLinical Evidence on Renal Survival in CKD patients with renal anemia (MIRACLE-CKD Study)
por: Hayashi, Terumasa, et al.
Publicado: (2018)

Direct health care cost of treatment and medication of biliary atresia patients using the National Database of Health Insurance Claims and Specific Health Checkups
por: Hoshino, Eri, et al.
Publicado: (2022)

A phase 3 safety study of fosnetupitant as an antiemetic in patients receiving anthracycline and cyclophosphamide: CONSOLE‐BC
por: Matsuura, Kazuo, et al.
Publicado: (2022)

Healthcare costs for the elderly in Japan: Analysis of medical care and long-term care claim records
por: Akiyama, Naomi, et al.
Publicado: (2018)

Valuation Survey of EQ-5D-Y Based on the International Common Protocol: Development of a Value Set in Japan
por: Shiroiwa, Takeru, et al.
Publicado: (2021)

Incident reports involving hospital administrative staff: analysis of data from the Japan Council for Quality Health care nationwide database
por: Akiyama, Naomi, et al.
Publicado: (2020)

Comparison of physicians’ and dentists’ incident reports in open data from the Japan Council for Quality Health Care: a mixed-method study
por: Akiyama, Naomi, et al.
Publicado: (2023)

Reported Incidents Involving Non-medical Care Workers and Nursery Teachers in Hospitals in Japan: An Analysis of the Japan Council for Quality Health Care Nationwide Database
por: Akiyama, Naomi, et al.
Publicado: (2022)

Realities in cost-effectiveness analyses: a study of castration-resistant prostate cancer patients using a medical claims database
por: Kunisawa, Susumu, et al.
Publicado: (2015)

The impact of interprofessional communication through ICT on health outcomes of older adults receiving home care in Japan – A retrospective cohort study
por: Yoshimoto, Takeru, et al.
Publicado: (2022)

Optimal follow-up intervals for different stages of chronic kidney disease: a prospective observational study
por: Hirano, Keita, et al.
Publicado: (2019)

A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients
por: Watanabe, Takanori, et al.
Publicado: (2019)

Reducing health inequities: the contribution of core public health services in BC
por: Pauly, Bernadette (Bernie), et al.
Publicado: (2013)

Kawasaki disease without changes in inflammatory biomarkers: A case report
por: Yamashita, Kosei, et al.
Publicado: (2022)

Critical Incident Reports Related to Ventilator Use: Analysis of the Japan Quality Council National Database
por: Akiyama, Naomi, et al.
Publicado: (2023)

Prospective observational study estimating willingness-to-pay for breast cancer treatments through contingent valuation method in Japanese breast cancer patients (JCOG1709A)
por: Iwatani, Tsuguo, et al.
Publicado: (2021)

A Mobile Health-Based Disease Management Program Improves Blood Pressure in People With Multiple Lifestyle-Related Diseases at Risk of Developing Vascular Disease　― A Retrospective Observational Study ―
por: Kanai, Masashi, et al.
Publicado: (2022)

Economic Evaluation of First-Line Pertuzumab Therapy in Patients with HER2-Positive Metastatic Breast Cancer in Japan
por: Moriwaki, Kensuke, et al.
Publicado: (2021)

Cost-effectiveness analysis of XELOX for metastatic colorectal cancer based on the NO16966 and NO16967 trials
por: Shiroiwa, T, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ld7ioemd2sa3s8mgv1uod0pnr4